Clinical trials
Phase 2 Non-alcoholic Fatty Liver Disease trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Tobira Therapeutics, Inc. | 2 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| Galmed Research and Development, Ltd. | 1 |
| HighTide Therapeutics (Hong Kong) Limited | 1 |
| NGM Biopharmaceuticals, Inc | 1 |
| Pfizer | 1 |
| Zhejiang Doer Biologics Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 13 |
| Liver Cirrhosis | 3 |
| Fibrosis | 2 |
| Diabetes Mellitus | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Fatty Liver | 1 |
| Liver Diseases | 1 |
| Obesity | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.